Abstract
AbstractIn an effort to reduce the conformational flexibility of the κ‐receptor selective opioid peptide dynorphin A, the cyclic analogues (I) and (II) are synthesized in reasonable yield by the solid phase technique using a protection scheme which permits the cyclization of the peptide still attached to the solid support.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have